Back

Colchicine in patients with coronary disease undergoing coronary artery bypass surgery: a meta-analysis of randomized controlled trials

1 September 2024 (07:55 - 08:40)
Organised by: Logo
Congress Presentation Part of: Risk stratification and treatment in patients undergoing CABG Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Hristo Kirov

University hospital Jena, Jena (Germany)

4 More presentations in this session

Presentation thumbnail
Clinical impact of Sarcopenia on long-term mortality in patients undergoing coronary bypass grafting
Doctor J. Jo (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
The impact of type 2 diabetes on short term myocardial morphological, functional, and energetic recovery post coronary artery bypass surgery in patients with ischemic heart disease
Doctor S. Kotha (Leeds, GB)
Abstract Slides Video
Presentation thumbnail
The utility of angiography-derived fractional flow reserve in predicting graft occlusions prior to bypass surgery
Doctor M. Buske (Leipzig, DE)
Abstract Slides Video
Presentation thumbnail
A randomized controlled trial of an eight-week cardiac rehabilitation home verse hospital exercise programme for post coronary cardiac bypass patients
Doctor M. Takroni (Riyadh, SA)
Abstract Slides Video

Access the full session

Session thumbnail
Risk stratification and treatment in patients undergoing CABG

The Event

Event poster

ESC Congress 2024

1 September 2024 07:55 CET
You may be interested in
thumbnail
Congress Presentation
Use of Colchicine in the Prevention of Perioperative Atrial Fibrillation after Non-cardiac Thoracic Surgery
thumbnail
Congress Presentation
Association of colchicine with atrial fibrillation and safety outcomes in patients with acute coronary syndrome
thumbnail
Congress Presentation
COP-AF - Colchicine for the prevention of perioperative atrial fibrillation after major thoracic surgery

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources